Skip to Main Content

Advertisement

Skip Nav Destination

Issues

TOP READS

J Immunol (2021) 206 (6): 1115.

BRIEF REVIEWS

J Immunol (2021) 206 (6): 1117–1125.

ALLERGY AND OTHER HYPERSENSITIVITIES

J Immunol (2021) 206 (6): 1127–1139.

  • T cells show elevated markers of metabolic capacity in lung inflammation in vivo.

  • IL-17–producing T cells show the most pronounced expression of metabolic markers.

  • Glut1 and GLS inhibitors reduce cytokine production and enhance steroid therapy.

ANTIGEN RECOGNITION AND RESPONSES

J Immunol (2021) 206 (6): 1140–1150.

  • CTL33 maintains intestinal microbiota homeostasis in shrimp.

  • CTL33 mediates biofilm formation of intestinal bacteria.

  • CTL33 facilitates the establishment of intestinal bacteria in shrimp intestines.

AUTOIMMUNITY

J Immunol (2021) 206 (6): 1151–1160.

  • Autoregulatory CD8 T cells contain a CXCR3+/IFN-γ+/IL-10+ subset.

  • CXCR3+ CNS-specific CD8 T cells can suppress EAE.

IMMUNE REGULATION

J Immunol (2021) 206 (6): 1161–1170.

  • CagA suppressed expression of proinflammatory cytokines in vitro and in vivo.

  • CagA interacted with SHP-1 which facilitated the recruitment of SHP-1 to TRAF6.

  • CagA interacts with SHP-1 to inhibit the K63-linked polyubiquitination of TRAF6.

J Immunol (2021) 206 (6): 1171–1180.

  • NK cells produce IL-10 during sepsis in an IL-15–dependent manner.

  • NK cell–derived IL-10 promotes host survival during sepsis.

  • NK cell–derived IL-10 is relevant to septic patients.

J Immunol (2021) 206 (6): 1181–1193.

  • Functional analysis of Th1* immune signature genes uncovers novel regulators of IFN-γ and IL-17.

  • Loss of ISOC1 impairs CD4+ T cell pyrimidine metabolism, bioenergetics, and cytokine production.

J Immunol (2021) 206 (6): 1194–1203.

  • IgG1 Fc peptides activate natural Treg, which regulate naive T cell differentiation.

  • Ag processing of the surface IgG on B cells activates Treg.

J Immunol (2021) 206 (6): 1204–1214.

  • Fibrocytes enable CD8+ T cell activation mainly via CD86/CD28 costimulation.

  • Fibrocytes express functional PD-L1; PD-L1 blockade further activates CD8+ T cells.

  • Tumor-infiltrating fibrocytes have APC function enhanced by PD-1/PD-L1 blockade.

IMMUNE SYSTEM DEVELOPMENT

J Immunol (2021) 206 (6): 1215–1227.

  • NK cells with unique receptor repertoires predominate at iNK, tNK, and mNK stages.

  • High interdependencies of NK cell receptor expression at the iNK stage were found.

  • In MHC-I–deficient mice, activating Ly-49 receptor expression is underrepresented.

J Immunol (2021) 206 (6): 1228–1239.

  • The FATC domain is critical for ATM protein stability in vivo.

  • R3047X mutation in ATM FATC domain blocks lymphocyte development.

  • ATM-R3047X has compromised tumor suppression functions.

INFECTIOUS DISEASE AND HOST RESPONSE

J Immunol (2021) 206 (6): 1240–1250.

  • We developed Macaca mulatta (Mamu) CD1b-GMM and CD1c-GMM tetramers.

  • i.v. BCG leads to expansion of CD1c-GMM–specific T cells in the blood.

  • Some CD1c-GMM–specific T cells express a TRM phenotype in BAL.

J Immunol (2021) 206 (6): 1251–1265.

  • Semaphorin 3E protects against chlamydial lung infection.

  • Semaphorin 3E modulates DC and T cell function for effective immune response.

J Immunol (2021) 206 (6): 1266–1283.

  • Vaccines were designed to induce only V1V2 Abs in NHP before SHIV challenge.

  • Vaccine-induced V2 Abs did not independently control SHIV infection.

  • Neutralizing and virus capture anti-Env Abs correlated with SHIV virus control.

J Immunol (2021) 206 (6): 1284–1296.

  • Neutralizing Ab-opsonized HIV was cleared faster from blood circulation than HIV.

  • FcγRIIb, the lone FcγR expressed in human LSEC, clears Ab-HIV via endocytosis.

  • Endocytosed Ab-HIV localizes to lysosomes of LSEC.

INNATE IMMUNITY AND INFLAMMATION

J Immunol (2021) 206 (6): 1297–1314.

  • Activation of TLR3+ moDCs predominates after respiratory viral infection.

  • TLR3 and moDCs are required for progressive postviral lung disease.

  • TLR3+ moDCs expand lung epithelial cells that are key to postviral disease.

J Immunol (2021) 206 (6): 1315–1328.

  • Early-life RSV infection persistently alters the immune phenotype in BMDC.

  • TSLP has a role in the altered immune environment by inhibiting type 1 immunity.

  • RSV infection alters immune responses through epigenetic/transcriptional programs.

J Immunol (2021) 206 (6): 1329–1336.

  • Tyrosine kinase inhibitors that target cAbl kinase inhibit inflammasome activation.

  • cAbl kinase deletion suppresses the ability to activate the NLRP3 inflammasome.

  • Tyrosine 146 of ASC is integral to speck formation and inflammasome function.

J Immunol (2021) 206 (6): 1337–1347.

  • Teleost IFNφ1 was discovered as a broad powerful bactericidal cytokine.

  • IFNφ1 directly kills bacteria by cytoderm binding and disruption.

  • Potent antimicrobial peptide–like IFN-Is were identified in other gnathostomes.

MUCOSAL IMMUNOLOGY

J Immunol (2021) 206 (6): 1348–1360.

  • SPM AT-RvD1 diminishes SHS-exacerbated, infection-induced pulmonary inflammation.

  • SHS-exposed mice demonstrated augmented antibacterial immunity when treated with AT-RvD1.

  • AT-RvD1–treated, SHS-exposed, vaccinated mice rapidly clear acute bacterial challenge.

SYSTEMS IMMUNOLOGY

J Immunol (2021) 206 (6): 1361–1371.

  • An IFN gene signature is present in the inflamed mucosa of individuals with EoE.

  • This IFN signature is conserved between adults and children.

  • IFN-γ is produced by circulating EoE T cells activated with EoE-causal allergens.

TUMOR IMMUNOLOGY

J Immunol (2021) 206 (6): 1372–1384.

  • Intratumoral T cells lose IFN-γ and GzmB and express elevated Tox and IL-10.

  • Agonistic αCD40 abrogates intratumoral IL-27, IL-10, and TEX.

  • αCD40+αPD-L1 and abrogating Tnfrsf1a on host cells promotes tumor clearance.

J Immunol (2021) 206 (6): 1385–1394.

  • CD155 is induced on macrophages in response to stimulation by IL-4 and LPS.

  • CD155 induction is dependent upon persistently active AhR.

  • CD155 can be targeted in vivo via AhR inhibition.

J Immunol (2021) 206 (6): 1395–1404.

  • ASAH2 is overexpressed in MDSCs in human colon cancer patients.

  • The Slc5a11–GSH–GPX4–lipid ROS ferroptosis pathway is regulated by Asah2 in MDSCs.

  • Inhibition of Asah2 by NC06 suppresses MDSC accumulation in tumor-bearing mice.

Close Modal

or Create an Account

Close Modal
Close Modal